-
Microplastics, Nanoplastics, and Pulmonary Fibrosis
2026-09-24
A comparative study tested polystyrene, polyethylene, and polypropylene particles at micro- and nanoscale sizes in mice and human lung epithelial cells. The findings associate smaller particles—particularly polystyrene nanoplastics—with stronger fibrotic and inflammatory responses, and identify FXR–YAP1 signaling as a candidate mechanism, while leaving important questions about human exposure and inhalation risk unresolved.
-
Diuron in Toxicology and Plant Biology Research
2026-09-24
Use Diuron to connect a defined photosynthesis-inhibiting herbicide mechanism with practical plant assays and emerging renal toxicology questions. This guide turns a 2025 network-toxicology study into a cautious, control-rich HK-2 cell workflow, with formulation and troubleshooting advice for more interpretable results.
-
7-dehydro Cholesterol: Research Workflows
2026-09-23
Build controlled assays around 7-dehydro Cholesterol to measure DHCR7-dependent sterol flux, UVB-driven vitamin D3 formation, and oxidation-sensitive lipid remodeling. The workflow also shows how chemical substrate exposure can complement—not replace—genetic evidence from antiviral fish research.
-
7-dehydro Cholesterol: From Sterol Flux to Immunity
2026-09-23
7-dehydro Cholesterol is more than a sterol intermediate: it is a mechanistic probe connecting DHCR7 activity, vitamin D3 formation, oxidative lipid biology, and antiviral phenotypes. This thought-leadership perspective translates recent dhcr7 knockout findings in grass carp into practical strategies for cholesterol biosynthesis research, skin models, and broader translational programs.
-
Anlotinib hydrochloride for Angiogenesis Assays
2026-09-22
Anlotinib hydrochloride provides a pathway-spanning way to interrogate VEGFR2, PDGFRβ, and FGFR1 in endothelial migration, tube formation, and signaling assays. This practical workflow connects concentration-response data with orthogonal angiogenesis models and troubleshooting strategies for reproducible cancer research.
-
Tacalcitol Sensitizes Colorectal Cancer Cells to 5-FU
2026-09-21
The reference study explains how tacalcitol, a synthetic analog of vitamin D3, enhances 5-fluorouracil activity in HT-29 colorectal cancer cells. Its central finding is a VDR-dependent induction of p21 that lowers thymidylate synthase, while epithelial differentiation markers and CaSR signaling provide additional mechanistic context for response prediction.
-
WST-8 Glucose Uptake Assay Kit for Liver Metabolism
2026-09-21
Translate insulin-resistance and steatosis phenotypes into quantitative, non-radioactive glucose uptake data with a workflow built around 2-DG and 450 nm colorimetry. The assay is especially useful for connecting Galectin-1–FIP200 biology with functional metabolic readouts in hepatic, diabetes, obesity, and cancer models.
-
Sumatriptan Succinate: 5-HT1 Workflow Guide
2026-09-20
Build reproducible migraine, neuroinflammation, and serotonergic signaling assays with Sumatriptan Succinate. A metabolism-focused workflow adds CYP1A2, CYP2C19, CYP2D6, and MAO A controls so receptor pharmacology is not confused with compound biotransformation.
-
Poly-PR, TDP-43 Condensation, and HSP70
2026-09-19
The reference study identifies a time-dependent mechanism linking C9ORF72-derived poly-PR stress to NEAT1-dependent TDP-43 nuclear condensation and altered HSP70 localization. Its findings position HSP70 as a regulator of condensate fluidity and TDP-43 proteostasis, while highlighting important limits when translating this neurodegenerative disease mechanism to other research settings.
-
Carboplatin Beyond DNA Damage: A Metabolic Lens
2026-09-19
Carboplatin is best known as a platinum-based DNA synthesis inhibitor, but its translational value extends beyond a conventional cytotoxicity readout. By integrating Carboplatin response studies with evidence that CIP2A drives PKM2 tetramerization and oxidative phosphorylation in non-small cell lung cancer, researchers can investigate how tumor metabolism, DNA damage, and model architecture jointly shape treatment response.
-
SB-3CT and MMP9: From PNNs to Translation
2026-09-18
A thought-leadership framework for using SB-3CT as a mechanistic gelatinase inhibitor in perineuronal-net, tumor metastasis, angiogenesis, and cerebral ischemia research—while preserving the distinction between pharmacological probing and clinical evidence.
-
Dhcr7 Editing Improves GCRV Resistance in Grass Carp
2026-09-18
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and identified DHCR7-dependent sterol metabolism as an in vivo determinant of resistance to lethal GCRV-II infection. Edited fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and less hepatopancreas injury without detectable defects in measured growth or muscle morphology.
-
Reversine for Reliable Mitotic Assays
2026-09-17
This scenario-driven guide explains how Reversine (SKU A3760) can support interpretable proliferation, viability, and apoptosis experiments through defined Aurora kinase pharmacology and practical handling controls. It also separates product-backed evidence from workflow recommendations and cautions against transferring cancer-cell findings directly to gastruloid models.
-
Ionomycin Calcium Salt in Ca2+ Influx Assays
2026-09-17
Ionomycin calcium salt is a versatile calcium ionophore for imposing controlled intracellular Ca2+ perturbations in cancer and cell-signaling studies. This article explains how to use it alongside the TSPAN18–STIM1–Orai1 model to distinguish calcium sufficiency from pathway-specific regulation.
-
REV1–DHX36 Coordination at G-Quadruplex DNA
2026-09-16
The 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tier model clarifies how cells tolerate stabilized G4 DNA while linking replication stress to ATM/ATR signaling and potential cancer research applications.